SCHEMBL1828667

SCHEMBL1828667

CCOC(=O)[C@@H](C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.35
ALDH1A1 P00352 5/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 2/20 0.33
HSD17B10 Q99714 1/20 0.33
HPGD P15428 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GAA P10253 2/20 0.32
ALOX15 P16050 1/20 0.32
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
SOAT1 P35610 1/20 0.32
TSHR P16473 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
KDM4E B2RXH2 1/20 0.31
METAP2 P50579 1/20 0.31
METAP1 P53582 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1578908 1.00 MMP8 (0.35) MMP8ALDH1A1KMT2ALMNAHSD17B10
SCHEMBL1578905 1.00 MMP8 (0.35) MMP8ALDH1A1KMT2ALMNAHSD17B10
SCHEMBL31054671 1.00 MMP8 (0.35) MMP8ALDH1A1KMT2ALMNAHSD17B10
SCHEMBL9558025 0.84
SCHEMBL9575398 0.82 ALDH1A1 (0.36) MMP8ALDH1A1KMT2ALMNAHSD17B10
SCHEMBL27915963 0.81 MMP8 (0.33) MMP8ALDH1A1LMNAHSD17B10HPGD
SCHEMBL26950806 0.81 MAPK1 (0.36)
SCHEMBL9462019 0.81 ALDH1A1 (0.36) MMP8ALDH1A1TSHR
SCHEMBL9462205 0.81 ALDH1A1 (0.36) MMP8ALDH1A1TSHR
SCHEMBL13573093 0.80 MMP8 (0.33) MMP8ALDH1A1LMNAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519239-A1 COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE Aarhus Universitet (DK) 2025-03-12 EP disclosed
US-20230399288-A1 LACTATE/KETONE BODY ESTERS AARHUS UNIVERSITET (DK) 2023-12-14 US disclosed
WO-2023213874-A1 COMBINED LACTATE AND KETONE BODY ESTERS FOR MEDICAL AND NUTRITIONAL USE AARHUS UNIVERSITET (DK) 2023-11-09 WO disclosed
EP-4240345-A1 LACTATE/KETONE BODY ESTERS Aarhus Universitet (DK) 2023-09-13 EP disclosed
WO-2022096637-A1 LACTATE/KETONE BODY ESTERS AARHUS UNIVERSITET (DK) 2022-05-12 WO disclosed
EP-1647551-B1 OPTICALLY ACTIVE HALOHYDRIN DERIVATIVE AND PROCESS FOR PRODUCING OPTICALLY ACTIVE EPOXY ALCOHOL DERIVATIVE FROM THE SAME KANEKA CORP (JP) 2011-05-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399288-A1 LACTATE/KETONE BODY ESTERS LDHB, LDHA, IL1B MMP8 1212/4885ALDH1A1 314/4885KMT2A 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.